Aortic Stenosis and Dialysis: Is TAVR the Strategy of Choice?

Courtesy of Dr. Carlos Fava.

acceso carotideo taviTAVR has been shown beneficial in high and moderate risk patients, but there is a group of patients that require dialysis on account of kidney deterioration.  This comorbidity is due to bad cardiovascular evolution associated to diabetes, bleeding and thromboembolic events.

 

For some time, we have been using an aortic valve percutaneous replacement strategy in this group, but there is little evidence of its benefits compared against surgical replacement.

 

This study included 1025 patients: 328 (32%) received TAVR (69 patients via transapical access) and 697 surgical aortic valve replacement (SAVR).


Read also: Differences in Stroke between TAVR and SAVR in Intermediate Risk Patients.


TAVR patients were older (75.3 vs. 61.6 mean age, P<0.001) and higher comorbidities index, such as heart failure (16.2% vs. 7.5%, P<0.001), diabetes (28.4% vs. 22.5%, P 0.05) and chronic obstructive pulmonary disease (27.7% vs. 20.4% p0 0.05). Instead, those undergoing SAVR more often had coagulation disorders (41.6% vs. 28.4% p>0.05), and neurological compromise (10.9% vs. 6.7% p<0.05) and took more drugs (3% vs. 0.6% p<0.05).

 

Using propensity score, patient population was matched into 175 pairs.

 

In-hospital mortality was similar (8% for TAVR vs. 10.3% for SAVR p=0.58). Patients undergoing TAVR had shorter hospitalization (8 vs. 14 days p<0.001), lower hospital cost (U$S 276.488 vs. U$S 364.280 p =0.01), fewer in-hospital complications (60.6% vs. 76% p 0.003) higher home discharge (76% vs. 60.6% p 0.004), in addition to less need for transfusion and fewer breathing complications.

 

Conclusion

Regardless treatment mortality, severe aortic stenosis patients have higher in-hospital mortality. TAVR and SAVR presented similar in-hospital mortality but TAVR was associated to shorter hospitalization, lower hospitalization cost, less in-hospital complications and higher discharge.

 

Courtesy of Dr. Carlos Fava.

 

Original Title: In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease.

Reference: Ahmad Alkhalil, et al. Cardiovasc Interv.  Catheter Cardiovasc Interv. 2018;92:757–765.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

TAVR in Young Low-Risk Patients

Transcatheter aortic valve replacement (TAVR) has established itself as an effective strategy for the treatment of severe aortic stenosis across different risk groups. While previous...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...